Adam Lenkowsky

Adam Lenkowsky is executive vice president and chief commercialization officer (CCO) at Bristol Myers Squibb. In this role, Adam leads the worldwide Commercial and Medical organizations and is responsible for driving growth across the company’s key franchises.

In his prior role, Adam was head of Major Markets, where he oversaw the commercialization business across 19 international markets, including Japan, Germany, U.K. and France.

He also served as general manager, U.S. Commercialization, overseeing Cardiovascular, Immunology and Oncology Commercialization at Bristol Myers Squibb.

Adam is passionate about cultivating a diverse and inclusive culture that prioritizes its people, performance, customers and, above all else, patients. He is an experienced leader who has held numerous senior strategic and operational roles across the company. He led the company’s U.S. Oncology business and the Worldwide Oncology Commercialization organization, having been instrumental in designing and creating the company’s integrated oncology operating model to drive speed and success for marketed and pipeline oncology assets.

Adam earned his bachelor’s degree in science from the State University of New York at Albany